BCM
VSTM icon

Bayesian Capital Management’s Verastem VSTM Stock Holding History

Bayesian Capital Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,367
Closed -$95K – 777
2018
Q4 		$95K Buy
+2,367
New +$145K 0.02% 559

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bayesian Capital Management's VSTM Position: Q1 2019 in Review

Bayesian Capital Management sold out of Verastem (VSTM) in Q1 2019, closing a stake of 2,367 shares — an estimated $95K sold.

Bayesian Capital Management first reported a position in VSTM in Q4 2018 and held it in 1 quarter. The position peaked at $95K in Q4 2018. 112 funds tracked by Wall St. Rank hold VSTM as of Q1 2019.

  • Bayesian Capital Management reported no remaining Verastem position as of Q1 2019 after selling out during the quarter.
  • Bayesian Capital Management sold 2,367 Verastem shares in Q1 2019, an estimated $95K.
  • Bayesian Capital Management first reported a position in Verastem in Q4 2018 and held it in 1 quarter.
  • Bayesian Capital Management's Verastem position peaked at $95K in Q4 2018.
  • 112 funds tracked by Wall St. Rank held Verastem as of Q1 2019.

Based on Bayesian Capital Management's 13F filing for Q1 2019, filed 14 May 2019.